NKTR

30.2007.19%
RB

Robert B. Chess

Lead Independent Director

Mr. Robert B. Chess, also known as Rob, MBA, serves as Director of Artisan Bio Inc. He has been Independent Chairman of the Board of Nektar Therapeutics since April 1999 and has been an Independent Director since May 1992. He serves as Director at BigHat Biosciences, Inc. since May 2022. He served as the Chief Executive Officer of OPX Biotechnologies, Inc. Mr. Chess served as Interim President and Chief Executive Officer of Nektar Therapeutics from March 17, 2006 to January 15, 2007 and from April 1999 to January 2007, served as Executive Chairman. He also served as Co-Chief Executive Officer from August 1998 to April 2000, President from December 1991 to August 1998 and Chief Executive Officer from May 1992 to August 1998 of Nektar Therapeutics. From September 1990 to October 1991, Mr. Chess served as an Associate Deputy Director and White House Fellow of the White House Office of Economic and Domestic Policy during the George H. W. Bush administration. He co-founded Penederm Inc. in March 1987 and served as its President until February 1989. Prior to Penederm, he held management positions at Intel Corp. and Metaphor Computer Systems. He is a Co-Founder of Biota Technologies and serves as its Chairman of the Board. He serves as Chairman of the Board of OPX Biotechnologies, Inc. He served as Chairman of BIO Ventures for Global Health. He was an Independent Director of Cotherix, Inc., since April 2004. He serves as a Director of Pelvalon, Inc. He has been Director of Twist Bioscience Corporation since July 2014 and is its Lead Independent Director since October 30, 2018. He serves as a Director of NanOasis Technologies, Inc. He serves as a Director of BIO Ventures for Global Health. Mr. Chess served as Director of Pharsight Corp. (formerly Certara Strategic Consulting) from April 2000 to August 2006 and Metabolex Inc. (now Cymabay Therapeutics, Inc.) from June 7, 2007 to April 2009. He served as a Director of Biotechnology Industry Organization (now Biotechnology Innovation Organization). He served as a Director of ChemGenex Therapeutics Inc. He is a Trustee of the Committee for Economic Development. He also serves on the Board of Trustees of the California Institute of Technology. He serves as a Director of Twist Bioscience. He serves on the faculty and a lecturer at the Stanford Graduate School of Business, where he teaches courses in the MBA program on starting technology-based businesses and the healthcare industry since 2004. Mr. Chess holds a B.S. in Engineering with honors from the California Institute of Technology (Caltech) and an M.B.A. from Harvard University.

Positions